Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Des mains de chercheuse qui manipulent

Major cross-functional projects

Last update: 10/03/2026 Reading time: 1min
Retour à la recherche

In 2024, Paris Brain Institute launched the ambitious initiative of major cross-functional, interdisciplinary and collaborative research programs.
 

Major cross-functional projects aim to make transformative contributions in their respective fields and to foster synergistic collaborations within the Institute and at the international level. The teams of Paris Brain Institute seek to build bridges between different disciplines, different approaches, and within a broad panel of neurodegenerative pathologies. The objective of this profoundly interdisciplinary approach is to create new fields of exploration at the interfaces, to allow the emergence of new ideas and hypotheses at the borders of current knowledge, by questioning current challenges in new ways. Some of these projects are conducted with international centres of research excellence, which represents a strategic approach to broadening the overall scope of our research.
 

Purpose of Major Cross-functional Projects

Purpose of Major cross-functional projects

The ultimate aim of these cross-functional  programmes is to open up concrete prospects by speeding up translational and clinical research into new treatments and solutions for the pathologies of the brain, with the idea of positively impacting the lives of nearly a billion patients worldwide by aiming at the prevention, repair or mitigation of the challenges posed by the pathologies of the brain.

The four Major cross-functional projects

The four Major cross-functional projects

  • Major cross-functional  project NEUROPREMS (project leaders: Alexandra Durr, Jean-Christophe Corvol) - Neurodegenerative and inflammatory markers in pre-symptomatic neurodegenerative diseases.
  • Major cross-functional  project Deep Brain Stimulation (DBS) (Project Leader Claire Wyart) - An approach to motor circuits linking genes to behaviour in Parkinson's disease. To learn more about the big DBS transversal project.
  • Major Cross-functional Project NEIMO (Project Leaders Jean-Léon Thomas, Stéphanie Lenck) - Neuroinflammation Surveillance, a collaborative initiative between Paris Brain Institute and Yale University (US).
  • Major Cross-functional project Brain Functional Genome Program (BFGP) (Project Leader: Bassem Hassan) - From Genomic Variation to Clinical Diagnosis: The Human Functional Genome Project.

News that might interest you

Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
See all our news